(King's College London) One of the most ambitious large-scale projects in Human Genetics has been launched today: Epitwin will capture the subtle epigenetic signatures that mark the differences between 5,000 twins on a scale and depth never before attempted, providing key therapeutic targets for the development of drug treatments. The project is a collaboration between TwinsUK, a leading twin research group based at King's College London, and BGI, one of the world's largest genomic organizations headquartered in Shenzhen, China.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Biology
- Steroids control gas exchange in plants
- New treatment for chronic pain after spinal cord injury
- Caltech researchers develop gene therapy to boost brain repair for demyelinating diseases
- Media alert: Society of Interventional Radiology's 37th Annual Scientific Meeting
- Boston University research suggests new pathways for cancer progression